These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 17532091

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.
    Souto EB, Doktorovova S, Gonzalez-Mira E, Egea MA, Garcia ML.
    Curr Eye Res; 2010 Jul; 35(7):537-52. PubMed ID: 20597640
    [Abstract] [Full Text] [Related]

  • 23. Targeting of nanoparticles in cancer: drug delivery and diagnostics.
    Talekar M, Kendall J, Denny W, Garg S.
    Anticancer Drugs; 2011 Nov; 22(10):949-62. PubMed ID: 21970851
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y, Fuchigami T, Tada N, Kawamura R, Matsunuma S, Kitamoto Y, Nakagawa M.
    Acc Chem Res; 2011 Oct 18; 44(10):1080-93. PubMed ID: 21786832
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Chapter 11 - Solid lipid nanoparticles for brain tumors therapy: State of the art and novel challenges.
    Brioschi AM, Calderoni S, Zara GP, Priano L, Gasco MR, Mauro A.
    Prog Brain Res; 2009 Oct 18; 180():193-223. PubMed ID: 20302836
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
    Tseng CL, Su WY, Yen KC, Yang KC, Lin FH.
    Biomaterials; 2009 Jul 18; 30(20):3476-85. PubMed ID: 19345990
    [Abstract] [Full Text] [Related]

  • 36. Nanostructured lipid carriers (NLC) in cosmetic dermal products.
    Müller RH, Petersen RD, Hommoss A, Pardeike J.
    Adv Drug Deliv Rev; 2007 Jul 10; 59(6):522-30. PubMed ID: 17602783
    [Abstract] [Full Text] [Related]

  • 37. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with cisplatin.
    Tian J, Pang X, Yu K, Liu L, Zhou J.
    Pharmazie; 2008 Aug 10; 63(8):593-7. PubMed ID: 18771008
    [Abstract] [Full Text] [Related]

  • 38. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review.
    Garcês A, Amaral MH, Sousa Lobo JM, Silva AC.
    Eur J Pharm Sci; 2018 Jan 15; 112():159-167. PubMed ID: 29183800
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.